Total submissions: 7
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Baylor Genetics | RCV000191100 | SCV000245499 | uncertain significance | Spastic ataxia 2 | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000859538 | SCV000572274 | likely benign | not provided | 2019-05-24 | criteria provided, single submitter | clinical testing | This variant is associated with the following publications: (PMID: 26633545, 31101064, 28832565) |
Unit for Genetic & Epidemiological Research on Neurological Disorders, |
RCV000516061 | SCV000574499 | uncertain significance | Hereditary spastic paraplegia | 2017-03-07 | criteria provided, single submitter | research | |
Labcorp Genetics |
RCV000191100 | SCV000767114 | benign | Spastic ataxia 2 | 2024-01-25 | criteria provided, single submitter | clinical testing | |
Ce |
RCV000859538 | SCV001151169 | likely benign | not provided | 2024-03-01 | criteria provided, single submitter | clinical testing | KIF1C: BP4, BS2 |
Genome Diagnostics Laboratory, |
RCV000516061 | SCV002105320 | uncertain significance | Hereditary spastic paraplegia | 2018-02-01 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV003917730 | SCV004728643 | likely benign | KIF1C-related disorder | 2020-02-14 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |